Bottom line
How much do FHLC and TMED overlap?
46% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 33.9% of FHLC's assets and 45.5% of TMED's. They share a meaningful core but differ in the rest of the portfolio.
FHLC holds far more positions (337 vs 102), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and TMED have in common
| Holding | % of FHLC | % of TMED | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 16.71% | 13.35% |
| UnitedHealth Group Inc | 5.44% | 6.52% | 5.44% |
| Thermo Fisher Scientific Inc | 3.09% | 4.11% | 3.09% |
| Gilead Sciences Inc | 2.34% | 4.44% | 2.34% |
| Pfizer Inc | 2.06% | 1.91% | 1.91% |
| Intuitive Surgical Inc | 1.82% | 2.43% | 1.82% |
| Danaher Corp | 1.80% | 2.96% | 1.80% |
| Stryker Corp | 1.62% | 2.22% | 1.62% |
| McKesson Corp | 1.52% | 1.46% | 1.46% |
| Cencora Inc | 0.83% | 2.75% | 0.83% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- Merck & Co Inc — 4.66%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Bristol-Myers Squibb Co — 1.93%
- CVS Health Corp — 1.92%
- Vertex Pharmaceuticals Inc — 1.76%
- Medtronic PLC — 1.59%
- Elevance Health Inc — 1.19%
- Regeneron Pharmaceuticals Inc — 1.15%
- Cigna Group/The — 1.06%
- Boston Scientific Corp — 1.00%
- HCA Healthcare Inc — 0.91%
- Cardinal Health Inc — 0.78%
Only in TMED
- Agilent Technologies Inc — 2.61%
- Alnylam Pharmaceuticals Inc — 2.60%
- Insulet Corp — 2.38%
- Dyne Therapeutics Inc — 2.03%
- Elanco Animal Health Inc — 1.91%
- Cytokinetics Inc — 1.69%
- Waters Corp — 1.68%
- West Pharmaceutical Services — 1.65%
- Ascendis Pharma A/s — 1.60%
- Biogen Inc — 1.55%
- Dexcom Inc — 1.46%
- Immunome Inc — 1.38%
- Biontech Se-adr — 1.29%
- Humana Inc — 1.24%
- Denali Therapeutics Inc — 1.22%
Asset mix
| Asset type | FHLC | TMED |
|---|---|---|
| Stocks | 99.7% | 99.3% |
| Cash & short-term funds | 0.2% | 0.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FHLC | TMED |
|---|---|---|
| US | 96.5% | 93.3% |
| IE | 2.2% | — |
| DK | — | 1.6% |
| DE | — | 1.6% |
| KY | — | 1.1% |
| NL | 0.1% | 0.9% |
| CH | 0.1% | 0.5% |
| GB | 0.5% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FHLC and TMED overlap?
What stocks do FHLC and TMED have in common?
Should I own both FHLC and TMED?
Which holds more stocks, FHLC or TMED?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.